{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:52:53Z","timestamp":1783651973084,"version":"3.55.0"},"reference-count":76,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":202,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p>Results from epidemiological studies and therapeutic clinical trials have shown that <jats:italic>Helicobacter pylori<\/jats:italic> infection causes acute and chronic active gastritis and is the initiating factor for the majority of peptic ulcer disease. Eradication of the infection with antibiotics resolves gastritis and restores normal gastric physiology, accelerates healing of peptic ulcer disease, and virtually eliminates recurrence of duodenal ulcer disease.<\/jats:p><jats:p>The infection also plays an important role in the initiation and\/or progression of gastric atrophy and intestinal metaplasia, which may eventually lead to the development of distal gastric cancer. Furthermore, almost all patients with gastric MALT lymphoma are infected with <jats:italic>H. pylori<\/jats:italic> and cure of the infection leads to histological regression of the tumor and maintains the regression in over 80% of patients during long\u2010term follow\u2010up.<\/jats:p><jats:p>Preliminary uncontrolled data from Japan show that eradication of the infection significantly reduced metachronous intestinal\u2010type gastric cancer following initial endoscopic resection of early gastric cancer and might also prevent the progression of gastric adenoma to gastric dysplasia or gastric cancer.<\/jats:p><jats:p>Although this overwhelming evidence has demonstrated that <jats:italic>H. pylori<\/jats:italic> infection is bad for humans, some have questioned the wisdom of eradicating the infection in all those infected. Their arguments are largely based on hypothesis and circumstantial evidence: 1) Less than 20% of all <jats:italic>H. pylori<\/jats:italic> infected persons will develop significant clinical consequences in their lifetime. 2) <jats:italic>H. pylori<\/jats:italic> strains are highly diverse at a genetic level and are of different virulence. 3) The antiquity of <jats:italic>H. pylori<\/jats:italic> infection in humans and their co\u2010evolution suggests that <jats:italic>H. pylori<\/jats:italic> may be a commensal to humans. Eradication of <jats:italic>H. pylori<\/jats:italic> may remove some beneficial bacterial strains and may provoke esophageal disease or gastric cancer at the cardia.<\/jats:p><jats:p>However, careful review of the literature confirms that <jats:italic>H. pylori<\/jats:italic> infection is a serious pathogen albeit in a minority of those infected. It remains for carefully designed prospective studies, rather than hypothesis to make changes in the current consensus position.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2001.00107.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:45:16Z","timestamp":1047354316000},"page":"51-59","source":"Crossref","is-referenced-by-count":21,"title":["Review article: should we kill or should we save <i>Helicobacter pylori<\/i>?"],"prefix":"10.1111","volume":"15","author":[{"given":"R.H.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sumanac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis.","author":"Warren JR","year":"1983","journal-title":"Lancet"},{"key":"e_1_2_8_3_2","unstructured":"International Agency for Research on Cancer.Schistosomes liver flukes andHelicobacter pyloriIARC monographs on the evaluation of carcinogenic risks to humans Vol. 61. Lion France: IARC 1994."},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301803"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70024-6"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70364-6"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007801"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02305.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(98)04206-8"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(97)00213-1"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.11.s1.7.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/314785"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)83893-6"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2000.01934.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80023-6"},{"key":"e_1_2_8_16_2","first-page":"281","article-title":"Changes in the gastric mucosa following eradication of Helicobacter pylori.","volume":"6","author":"Genta RM","year":"1993","journal-title":"Mod Pathol"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109003956"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-9896(199905)188:1<24::aid-path316>3.3.co;2-6"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012070-00001"},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","unstructured":"HowdenCW.What causesHelicobacter pylori\u2010negative non\u2010NSAID\u2010related ulcers.In: Hunt RH Tytgat GNJ eds.Helicobacter pyloriBasic Mechanisms to Clinical Cure 2000. London: Kluwer Academic Publishers 2000 pp.339\u201346.","DOI":"10.1007\/978-94-011-3927-4_37"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-12-199406150-00001"},{"key":"e_1_2_8_22_2","first-page":"59","article-title":"The prevalence of Helicobacter pylori in peptic ulcer disease.","volume":"9","author":"Kuipers EJ","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00333.x"},{"key":"e_1_2_8_24_2","first-page":"A93","article-title":"Antimicrobials accelerate healing of duodenal ulcer (DU) when given with proton pump inhibitors (PPI) or H2\u2010receptor antagonists (H2RA): a meta\u2010analysis.","volume":"41","author":"Huang JQ","year":"1997","journal-title":"Gut"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609036903"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00531.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529708996512"},{"key":"e_1_2_8_28_2","first-page":"1914","article-title":"Does initial choice of Helicobacter pylori (HP) treatment regimen influence the recurrence rate of duodenal ulcer (DU)? A meta\u2010analysis.","volume":"91","author":"Huang JQ","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509090275"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00278.x"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012070-00003"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402103300602"},{"key":"e_1_2_8_33_2","first-page":"1549","article-title":"Antimicrobial therapy for Helicobacter pylori infection versus long\u2010term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.","volume":"91","author":"Santander C","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.23.1777"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70422-6"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91034-0"},{"key":"e_1_2_8_37_2","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process \u2013 First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.","volume":"52","author":"Correa P.","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70159-3"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.3.322"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/35006081"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70410-0"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)85035-0"},{"key":"e_1_2_8_43_2","first-page":"639","article-title":"Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.","volume":"6","author":"Uemura N","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2000.106112"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90113-2"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-57054-4_16"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70132-1"},{"key":"e_1_2_8_48_2","first-page":"A49","article-title":"Is there a causal relationship between H.\n                  pylori infection and gastric maltoma? A meta\u2010analysis of evidence from epidemiological studies and clinical trials.","volume":"41","author":"Huang JQ","year":"1997","journal-title":"Gut"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80003-0"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1155\/1999\/180751"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_8_52_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1998.tb00537.x","article-title":"Helicobacter pylori consensus: Report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection.","volume":"13","author":"Lam SK","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00776.x"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199903000-00010"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.465"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/28.1.54"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01929.x"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00758.x"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00677.x"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.014s1161.x"},{"key":"e_1_2_8_61_2","first-page":"A249","article-title":"Symptomatic benefit 1\u20133 years post H. pylori eradication in ulcer patients: Impact of reflux disease.","volume":"116","author":"McColl K","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_8_62_2","first-page":"A173","article-title":"No occurrence of reflux oesophagitis following Helicobacter pylori eradication in duodenal ulcer patients \u2013 A 5 year endoscopic follow\u2010up in South\u2010East Asian patients.","volume":"116","author":"Goh KL","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80862-7"},{"key":"e_1_2_8_64_2","first-page":"A117","article-title":"Does eradication of Helicobacter pylori influence the recurence of symptoms in patients with symptomatic gastro\u2010oesophageal reflux disease? \u2013 A randomised double blind study.","volume":"116","author":"Axon AT","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00544.x"},{"key":"e_1_2_8_66_2","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1572-0241.1999.01207.x","article-title":"Prevalence and distibution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East.","volume":"94","author":"Wu JC","year":"1999","journal-title":"Am J Gastro"},{"key":"e_1_2_8_67_2","first-page":"588","article-title":"An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.","volume":"58","author":"Chow WH","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.181"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109098227"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70075-1"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00306.x"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.1999.0066"},{"key":"e_1_2_8_73_2","doi-asserted-by":"crossref","unstructured":"HuangJ\u2010Q LadR HuntRH.Role ofHelicobacter pyloriinfection in NSAID\u2010associated gastropathy.In: Hunt RH Tytgat GNJ eds.Helicobacter pyloriBasic Mechanisms to Clinical Cure 2000. London: Kluwer Academic Publishers 2000 pp.443\u201351.","DOI":"10.1007\/978-94-011-3927-4_47"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)04523-6"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)83076-0"},{"key":"e_1_2_8_76_2","first-page":"2453","article-title":"Meta\u2010analysis of the role of Helicobacter pylori in non\u2010steroidal anti\u2010inflammatory drug (NSAID)\u2010associated gastropathy.","volume":"95","author":"Huang J\u2010Q","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890008995946"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00107.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00107.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00107.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:28:27Z","timestamp":1695806907000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00107.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":76,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00107.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00107.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}